Aarti Drugs Limited’s Board of Directors has approved the ‘Aarti Drugs Limited Performance Stock Option Plan 2026’ (PSOP 2026). This plan allows for the creation and grant of up to 8,00,000 stock options, convertible into an equal number of equity shares. These options will be offered to eligible employees, subject to member approval, aligning employee interests with company performance.
Aarti Drugs Announces Employee Stock Option Plan
The Board of Directors at Aarti Drugs Limited convened today, August 27, 2026, and made a significant decision concerning employee incentives. The board has considered and approved the new ‘Aarti Drugs Limited Performance Stock Option Plan 2026’, referred to as ‘PSOP 2026’.
Key Details of the Stock Option Plan
Under the approved ‘PSOP 2026’ plan, the company is authorized to create and grant a maximum of 8,00,000 (Eight Lakh) Performance Stock Options. These options are intended to be convertible into an equal number of equity shares of the company, each with a face value of Rs. 10/-. The grant of these options is designated for eligible employees, as per the provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The implementation of this plan is contingent upon securing the necessary approval from the company’s members.
Board Meeting Concluded
The Board Meeting commenced at 11:30 AM and concluded at 12:20 PM on the same day. All approved resolutions have been noted for records.
Source: BSE
